Afrezza

BIOLOGICAL3 trials

Sponsors

Mannkind Corporation

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Type 1 Diabetes Mellitus

Phase 2

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

CompletedNCT02527265

Mannkind CorporationType 1 Diabetes Mellitus

Start: 2017-09-28End: 2020-06-25Updated: 2021-04-06

Phase 3

Afrezza® INHALE-1 Study in Pediatrics

CompletedNCT04974528

Mannkind CorporationDiabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2021-09-29End: 2025-04-29Updated: 2025-05-06

Phase 4

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

CompletedNCT05904743

Mannkind CorporationDiabetes Mellitus, Type 1

Start: 2023-07-07End: 2024-06-24Updated: 2024-08-09

Related Papers

Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.

2023-01-184 citations